Quadramet and lymphadenopathy Patient Reports February 12, 2012

Quadramet Side Effects Report #4680206-7
Quadramet side effect was reported by a Physician from on Dec 06, 2004. Male patient was diagnosed with prostate cancer metastatic and was treated with Quadramet. After drug was administered, patient experienced the following side effects: anaemia, lymphadenopathy, malignant neoplasm progression, nausea , pain , platelet count decreased, prostate cancer , white blood cell count decreased. Quadramet dosage: unknown. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient recovered.

Quadramet Side Effects Report #4680208-0
Quadramet side effect was reported by a Physician from on Dec 01, 2004. Male patient was diagnosed with prostate cancer metastatic and was treated with Quadramet. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urine present, haemoglobin decreased, lymphadenopathy, obstructive uropathy. Quadramet dosage: unknown. During the same period patient was treated with ZOMETA, GOSERELIN, CAPTOPRIL W, IBUPROFEN, PARACETAMOL, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Quadramet Side Effects Report #4596602-2
Quadramet side effect was reported by a Physician from on Feb 11, 2005. Male patient, 53 years of age, weighting 224.9 lb, was diagnosed with bone cancer metastatic, prostate cancer  and was treated with Quadramet. After drug was administered, patient experienced the following side effects: anxiety , benign prostatic hyperplasia, bladder disorder, gout , headache , hydronephrosis, hypertension, lymphadenopathy, nausea . Quadramet dosage: unknown. During the same period patient was treated with INDOCIN, FLOMAX, TOPROIL, ATIVAN, NORVASC. Patient was hospitalized. Patient recovered.

Quadramet Side Effects Report #5877997-6
Quadramet side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 09, 2008. Male patient, weighting 190.0 lb, was treated with Quadramet. After drug was administered, patient experienced the following side effects: bloody discharge, body temperature increased, disease progression, hydronephrosis, hypotension, lung disorder, lymphadenopathy, mediastinal disorder, neutropenia. Quadramet dosage: unknown. During the same period patient was treated with ZOMETA, LUPRON, MITOXANTRONE. Patient was hospitalized. Patient recovered.